Mostrar el registro sencillo del ítem

dc.contributor.author
Gredilla, Ricardo  
dc.contributor.author
Villa, Ivana  
dc.contributor.author
Reines, Analia Gabriela  
dc.contributor.author
Stevnsner, Tinna  
dc.contributor.author
Zarate, Sandra Cristina  
dc.date.available
2023-08-24T14:50:51Z  
dc.date.issued
2021  
dc.identifier.citation
Regional differential effects of hormone-replacement treatments on mitochondrial DNA repair mechanism are not exerted through gene expression regulation in the brain; LXVI Reunión Anual de la Sociedad Argentina de Investigación Clínica; LXIX Reunión Anual de la Sociedad Argentina de Inmunología; LIII Reunión Anual de la Asociación Argentina de Farmacología Experimental y XI Reunión Anual De La Asociación Argentina De Nanomedicinas; Argentina; 2021; 203-204  
dc.identifier.issn
1669-9106  
dc.identifier.uri
http://hdl.handle.net/11336/209283  
dc.description.abstract
The brain is highly susceptible to mitochondria dysfunction and oxidative stress due to its high demand of energy and low antioxidant capacity. Mitochondrial DNA (mtDNA) is specially vulnerable to oxidative damage and Base Excision Repair (BER) is the main mtDNA repair mechanism. Ovarian hormone loss during natural or induced reproductive senescence is associated with mitochondrial alterations, synaptic decline and increased risk of age-related diseases.The aim of this work was to assess whether hormone-replacement treatments affect the expression of BER enzymes to explain previous results regarding the differential activity of such enzymes in the hippocampus (Hp) and cerebral cortex (Cc) of hormone-treated ovariectomized (OVX) rats. To this aim, adult OVX or sham-operated (SHAM) rats were s.c. with empty or containing estradiol (E) and/or progesterone (P) silastic capsules. After 12 weeks, cDNA was obtained from total RNA extracted from the Hp and Cc and amplified by qPCR using specific primers for BER enzymes.The expression of DNA glycosylases was either lower o similar to SHAM group in both Hp and Cc of OVX rats (NEIL1 p<0,01; NEIL2 p<0,05; UNG1 p<0,01; OGG1 ns; Student´s t test). Similar results were obtained for the rest of the enzymes of the pathway (AP endonuclease1, γ-polymerase and lygase3 p<0,05, Student´s t test). Hormone treatments did not affect the expression of OGG1, NEIL2 or UNG1 in any brain region, but increased the expression of NEIL1 only in the Hp (E+P p<0,05; ANOVA). On the other hand, P alone or combined with E, increased the expression of the rest of the enzymes of the pathway in both brain regions (p<0,05; ANOVA).Our results show that OVX decreases the expression of BER enzymes in both brain regions and that there is no association between ARNm levels and the activity of such enzymes in hormone-treated rats. Thus, hormones exert their regional differential action on BER pathway through a mechanism not involving gene regulation.  
dc.format
application/pdf  
dc.language.iso
eng  
dc.publisher
Fundación Revista Medicina  
dc.rights
info:eu-repo/semantics/openAccess  
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/  
dc.subject
MITOCHONDRIA  
dc.subject
BRAIN  
dc.subject
DNA REPAIR  
dc.subject
HORMONE REPLACEMENT TREATMENT  
dc.subject.classification
Neurociencias  
dc.subject.classification
Medicina Básica  
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD  
dc.title
Regional differential effects of hormone-replacement treatments on mitochondrial DNA repair mechanism are not exerted through gene expression regulation in the brain  
dc.type
info:eu-repo/semantics/publishedVersion  
dc.type
info:eu-repo/semantics/conferenceObject  
dc.type
info:ar-repo/semantics/documento de conferencia  
dc.date.updated
2022-11-09T18:53:50Z  
dc.journal.volume
81  
dc.journal.number
III  
dc.journal.pagination
203-204  
dc.journal.pais
Argentina  
dc.journal.ciudad
Buenos Aires  
dc.description.fil
Fil: Gredilla, Ricardo. Universidad Complutense de Madrid; España  
dc.description.fil
Fil: Villa, Ivana. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Biomédicas. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Biomédicas; Argentina  
dc.description.fil
Fil: Reines, Analia Gabriela. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Biología Celular y Neurociencia "Prof. Eduardo de Robertis". Universidad de Buenos Aires. Facultad de Medicina. Instituto de Biología Celular y Neurociencia; Argentina  
dc.description.fil
Fil: Stevnsner, Tinna. Aarhus University. Department of Bioscience; Dinamarca  
dc.description.fil
Fil: Zarate, Sandra Cristina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Biomédicas. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Biomédicas; Argentina  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://medicinabuenosaires.com/revistas/vol81-21/s3/Mv81s3.pdf  
dc.conicet.rol
Autor  
dc.conicet.rol
Autor  
dc.conicet.rol
Autor  
dc.conicet.rol
Autor  
dc.conicet.rol
Autor  
dc.coverage
Nacional  
dc.type.subtype
Reunión  
dc.description.nombreEvento
LXVI Reunión Anual de la Sociedad Argentina de Investigación Clínica; LXIX Reunión Anual de la Sociedad Argentina de Inmunología; LIII Reunión Anual de la Asociación Argentina de Farmacología Experimental y XI Reunión Anual De La Asociación Argentina De Nanomedicinas  
dc.date.evento
2021-11-17  
dc.description.paisEvento
Argentina  
dc.type.publicacion
Journal  
dc.description.institucionOrganizadora
Sociedad Argentina de Investigación Clínica  
dc.description.institucionOrganizadora
Sociedad Argentina de Inmunología  
dc.description.institucionOrganizadora
Asociación Argentina de Farmacología Experimental  
dc.description.institucionOrganizadora
Asociación Argentina de Nanomedicinas  
dc.source.revista
Medicina  
dc.date.eventoHasta
2021-11-20  
dc.type
Reunión